<DOC>
	<DOCNO>NCT01047345</DOCNO>
	<brief_summary>This study evaluate whether V503 ( 9vHPV vaccine ) , well tolerated girl woman 12 26 year old previously vaccinate GARDASIL™ . Participants receive vaccination 9vHPV vaccine placebo Day 1 , Month 2 , Month 6 Base Study . Participants receive placebo Base Study eligible receive vaccination 9vHPV vaccine Day 1 , Month 2 , Month 6 Extension Study .</brief_summary>
	<brief_title>A Study V503 , 9-valent Human Papillomavirus ( 9vHPV ) Vaccine Females 12-26 Years Age Who Have Previously Received GARDASIL™ ( V503-006 )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participants Age 12 15 Years : Participant good health Parent/legal guardian participant agree provide study personnel primary telephone number followup Participant receive 3dose regimen market GARDASIL™ within 1 year period last dose GARDASIL™ least 1 year study day 1 Participant receive HPV vaccine Participant yet sexually active Participants Age 16 26 Years : Participant good health Participant agree provide primary telephone number followup Participant receive 3dose regimen market GARDASIL™ within 1 year period last dose GARDASIL™ least 1 year study day 1 Participant receive HPV vaccine Participant never Papanicolaou ( Pap ) test normal result Participant history 0 4 lifetime sexual partner enrollment All participant : Participant history severe allergic reaction require medical intervention Participant disorder would contraindicate intramuscular injection Participant pregnant Participant immunocompromised autoimmune condition Participant splenectomy Participant receive immune globulin product bloodderived product Participant participate HPV vaccine clinical trial Participants Age 16 26 Only : Participant expect donate egg study Participant history abnormal cervical biopsy result Participant history HPVrelated external genital lesion , external genital cancer , HPVrelated vaginal lesion , vaginal cancer</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cervical cancer</keyword>
	<keyword>Genital wart</keyword>
	<keyword>Human papillomavirus vaccine</keyword>
	<keyword>GARDASIL™</keyword>
</DOC>